EU fines world’s largest generic drugmaker Teva for hindering competition
European Commission says company abused ‘dominant position’ to ‘artificially’ extend patent protection of MS medicine Copaxone
Read more at Financial Times
Topics
-
EU fines world’s largest generic drugmaker Teva for hindering competition
World - Financial Times - 4 hours ago -
Teva Fined Around $500 Million Over MS Drug Competition Concerns
Business - The Wall Street Journal - 4 hours ago -
Intel wins lengthy EU legal battle over £880m competition fine
World - The Guardian - October 24 -
EU Commission fines Teva $500M for trying to stop rival's multiple sclerosis drug
World - ABC News - 3 hours ago -
EU Commission fines Teva $500 million for trying to stop rival's multiple sclerosis drug
Health - ABC News - 3 hours ago -
EU weighs including Musk’s business empire to calculate potential X fine
Business - Financial Times - October 17 -
Trump Says Apple CEO Tim Cook Called Him Over EU Fines
Business - Inc. - October 18
More from Financial Times
-
UK borrowing costs hit highest level this year as gilt sell-off intensifies
Business - Financial Times - 54 minutes ago -
The start of a new round of gilt market carnage?
Business - Financial Times - 2 hours ago -
UK savings plans overhauled with planned pension tax changes
Business - Financial Times - 20 minutes ago -
How Rachel Reeves will reform carried interest taxation
Business - Financial Times - 1 hour ago -
The Budget should not be a big deal for interest rates
Business - Financial Times - 1 hour ago
Latest in Business
-
Apple to report earnings as investors worry about 'mixed' iPhone demand
Business - CNBC - 3 minutes ago -
Comcast is exploring separation of cable networks business
Business - CNBC - 8 minutes ago -
Meta Earnings Show Revenue Increase, Even as Spending Spree Continues
Business - The New York Times - 20 minutes ago -
UK savings plans overhauled with planned pension tax changes
Business - Financial Times - 20 minutes ago -
British aerospace pioneer Reaction Engines collapses into administration
Business - Financial Times - 20 minutes ago